Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Epstein-Barr Virus Infections × spartalizumab × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Epstein-Barr Virus Infections 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

spartalizumab 1 ruxolitinib 1 dolutegravir 1 Ritonavir 1 Nucleosides 1 Dexamethasone 1 Darunavir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05039580 2021-09-09

SEHC

The First Affiliated Hospital of Soochow University

Phase 4 Unknown

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡